WZWen-Jun Zhou

Wen-Jun Zhou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wen-Jun Zhou has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Chuan Huang

    Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha 410006, China

    1 shared publication
  • Hui-Lan Wu

    Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha 410006, China

    1 shared publication
  • Liqing Fan

    NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Institute of Reproductive and Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China

    1 shared publication
  • Qian Liu

    Institute of Reproductive and Stem Cell Engineering, Basic Medicine College, Central South University, Changsha 410000, China

    1 shared publication
  • Wen-Bing Zhu

    Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, Hunan, China; Institute of Reproductive and Stem Cell Engineering, Basic Medicine College, Central South University, Changsha, Hunan, China

    1 shared publication
  • Xi-Ren Ji

    Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha 410006, China

    1 shared publication

Latest Publications

  • Open Access

    Comparison of Clinical Outcomes, Risks, and Costs for 20,910 Donor In Vitro Fertilization and 16,850 Donor Artificial Insemination Treatment Cycles: A Retrospective Analysis in China

    by Xue-Feng Luo, Hui-Lan Wu, Xi-Ren Ji, Yu-Lin Tang, Wen-Jun Zhou, Zeng-Hui Huang, Qian Liu, Li-Qing Fan, Chuan Huang, Wen-Bing Zhu

    Purpose: To evaluate the effectiveness of donor in vitro fertilization (IVF-D) and donor artificial insemination (AI-D) in clinical outcomes, risks, and costs. Methods: This study analyzed the cycle changes and clinical outcomes in 20,910 IVF-D and 16,850 AI-D cycles between 2013 and 2021 in the Reproductive and Genetic Hospital of CITIC-Xiangya. A cost-effectiveness analysis was performed to evaluate the costs per couple and per live birth cycle in the two treatment groups. Results: IVF-D had higher pregnancy and live birth rates than AI-D (p < 0.001). The cumulative pregnancy and live birth rates for three AI-D cycles were 41.01% and 32.42%, respectively, higher than the rates for one or two AI-D cycles. The multiple birth and birth defect rate of AI-D was lower than that of IVF-D significantly. IVF-D mean cost per couple was higher than that of AI-D (CNY32,575 vs. CNY11,062, p < 0.001), with a mean cost difference of CNY21,513 (95% confidence interval, CNY20,517–22,508). The mean costs per live birth cycle for IVF-D and AI-D were CNY49,411 and CNY31,246, respectively. Conclusion: AI-D is more cost-effective and poses a lower risk for infertility couples than IVF-D, and patients should undergo three AI-D cycles to obtain the highest success rate.